| Financial Year |
March 31 2023 |
| Monetary Funds |
7,777,217,591.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,673,329,077.41 |
| Accounts Receivable |
739,980,720.73 |
| Advances to Suppliers |
1,198,337,070.28 |
| Other Receivables |
283,399,803.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,596,497,495.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
291,948,104.35 |
| Total Current Assets |
26,560,709,863.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,674,135.78 |
| Investment Properties |
7,110,306.58 |
| Fixed Assetes |
36,662,673,624.46 |
| Under-construction Projects |
9,116,672,732.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,297,953,839.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
889,295,787.78 |
| Other Non-Current Assets |
61,545,381.14 |
| Sub-Total of Non-Current Assets |
48,070,685,689.59 |
| Total Assets |
74,631,395,552.88 |
| Short-Term Loans |
2,394,593,000.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,984,197,830.24 |
| Accounts Payable |
11,886,973,788.92 |
| Accounts Received In Advance |
55,140,000.00 |
| Employee Compensation Payable |
173,306,448.68 |
| Taxes Payable |
13,619,478.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
695,559,380.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,157,325,994.67 |
| Other Current Liabilities |
1,156,823,357.94 |
| Sub-Total of Current Liabilities |
28,189,717,623.21 |
| Long-term Loans |
22,266,430,731.02 |
| Bonds Payable |
998,947,513.04 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
161,423,800.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,614,756,534.34 |
| Total Liabilities |
51,804,474,157.55 |
| Paid-In Capital(Or Share Stock) |
2,562,793,200.00 |
| Capital Surplus |
120,932,457.86 |
| Surplus Reserve |
2,181,361,710.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,207,865,673.39 |
| Minority Stockholder's Interest |
12,745,176,638.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,081,744,756.66 |
| Owner's Equity（Stockholder's Equity） |
22,826,921,395.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
74,631,395,552.88 |
